MedPage Today on MSN
Cannabis combination eased end-of-life agitation in dementia patients
Nearly 90% of trial participants improved with treatment ...
3don MSN
Cannabis-derived treatment eases agitation in hospice-eligible dementia patients, trial finds
In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a special medical formulation of two active ingredients found in ...
A combination of THC and CBD eased symptoms in an especially frail population: patients with advanced dementia near the end ...
When is it time to consider hospice care? Hospice care is a type and philosophy of care that centers on the palliation of a terminally or seriously ill patient's pain and symptoms and attending to ...
A new study reveals a purified medical THC/CBD oil formulation drastically reduces severe agitation in late-stage dementia.
The authors explored hospice clinician and caregiver perspectives on behavioral and psychological symptoms of dementia (BPSD) and their management. BPSD are common and challenging, impacting both ...
Patients with Alzheimer’s disease experienced rapid and significant improvements in agitation with a combination of CBD and ...
Hospice care aims to bring comfort, peace, and dignity to patients at the end of life. Yet for the growing number of Americans with dementia who enter hospice, their course is often long and ...
Patients with advanced dementia near the end of their lives experienced an easing of symptoms after receiving THC/CBD ...
Newly prescribed benzodiazepines or antipsychotics were tied to higher mortality for dementia patients in hospice. The drugs were started a median of 3 days after hospice enrollment and the mean stay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results